Latest Breaking News On - Tony plohoros - Page 2 : comparemela.com

Atsena Therapeutics Announces Initiation of Dosing in Second Cohort of Phase I/II Clinical Trial Evaluating ATSN-201 Gene Therapy for the Treatment of X-linked Retinoschisis (XLRS)

Atsena Therapeutics Announces Initiation of Dosing in Second Cohort of Phase I/II Clinical Trial Evaluating ATSN-201 Gene Therapy for the Treatment of X-linked Retinoschisis (XLRS)
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Tony plohorosKenji fujitaSafety monitoring boardChief medical officerX linked retinoschisisAbout atsena therapeuticsatsena therapeutics

Journey Medical Corporation Announces Presentation of Data

Clinical trial achieved all three primary objectives and subjects completed 16-week treatment with no significant safety issues Results indicate that.

United statesSan diegoTony plohorosClaude maraouiSrinivas sidgiddiJaclyn jaffeJourney medical corporation nasdaqSecurities exchangeExchange commissionFortress biotech incReddy laboratories ltdAmerican academy of dermatologyResearch development of journeyCompany contactNational rosacea societyJourney medical corporation

Atsena Therapeutics Receives Rare Pediatric Disease Designation from FDA for ATSN-101 Gene

DURHAM, N.C., Jan. 16, 2024 (GLOBE NEWSWIRE) Atsena Therapeutics, a clinical-stage gene therapy company focused on bringing the life-changing power of genetic medicine to reverse or prevent blindness, today

United statesNorth carolinaPatrick ritschelChristine nichols kaySanford boyeShannon boyeTony plohorosMacula society meetingCarolina research triangleDrug administrationUniversity of floridaRare pediatric diseaseRegenerative medicine advanced therapyBiologics license applicationPriority review voucherPediatric disease

Journey Medical Corporation Secures Credit Facility with SWK Holdings for up to $20 Million

Journey Medical Corporation Secures Credit Facility with SWK Holdings for up to $20 Million
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesClaude maraouiTony plohorosJaclyn jaffeFortress biotech incSecurities exchangeJourney medical corporationjourney corporation nasdaqDrug administrationCompany contactJourney medical corporation nasdaqHoldings corporationJourney medical corporationExchange commissionMedical corporationJourney medicalNew drug application

Fortress Biotech Announces Pricing of $11 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

MIAMI, Dec. 29, 2023 Fortress Biotech, Inc. , an innovative biopharmaceutical company focused on efficiently acquiring, developing and commercializing or monetizing promising therapeutic.

United statesTony plohorosJaclyn jaffeFred hutchinson cancer centerFortress or companyResearch hospitalGlobenewswire incExchange commissionCompany contactFortress biotech incSecurities exchangeRoth capital partnersCapital partnersClemente driveHutchinson cancer centerJude children